COVID vaccine
University of Hong Kong, Sinopharm launch trial of Omicron-targeting vaccine
University of Hong Kong, Sinopharm launch trial of Omicron-targeting vaccine
A total of 1,800 adult volunteers will be needed for the trial.
Read Here
Advertise
Sign Up
Commentary
The strategic decarbonisation model for Hong Kong real estate
The survival playbook for the CEO amidst geopolitical conflicts
The succession shift: Redesigning wealth structures for the next generation
2026 biotech playbook: Hong Kong at the centre of China’s globalisation